Quaterly Results | Vivimed Labs Ltd. | R Wadiwala Securities Pvt Ltd

VIVIMED LABS LTD.

NSE : VIVIMEDLABBSE : 532660ISIN CODE : INE526G01021Industry : Pharmaceuticals & DrugsHouse : Private
BSE5.520.26 (+4.94 %)
PREV CLOSE (Rs.) 5.26
OPEN PRICE (Rs.) 5.15
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 16605
TODAY'S LOW / HIGH (Rs.)5.15 5.52
52 WK LOW / HIGH (Rs.)5.15 27.99
NSE5.530.25 (+4.73 %)
PREV CLOSE( Rs. ) 5.28
OPEN PRICE (Rs.) 5.15
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 115252
TODAY'S LOW / HIGH(Rs.) 5.15 5.54
52 WK LOW / HIGH (Rs.)5.15 29.4

Quarterly Results

Quarters
Select year
Particulars
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
159.89
206.12
213.88
256.14
Total Expenditure
269.11
215.67
216.70
280.78
PBIDT (Excl OI)
-109.22
-9.55
-2.82
-24.64
Other Income
NA
2.12
3.78
42.17
Operating Profit
-109.22
-7.42
0.96
17.53
Interest
10.04
16.55
5.76
17.40
Exceptional Items
NA
NA
NA
NA
PBDT
-119.26
-23.97
-4.80
0.13
Depreciation
46.28
49.04
50.13
55.00
Profit Before Tax
-165.54
-73.01
-54.93
-54.87
Tax
NA
NA
NA
1.13
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
-165.54
-73.01
-54.93
-56.00
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
-165.54
-73.01
-54.93
-56.00
Minority Interest
NA
NA
NA
NA
Shares of Associates
Other related items
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
-165.54
-73.01
-54.93
-56.00
Equity Capital
165.83
165.83
165.83
165.83
Face Value (IN RS)
2.00
2.00
2.00
2.00
Reserves
NA
NA
NA
NA
Calculated EPS
-2.00
-0.88
-0.66
-0.68
Calculated EPS (Annualised)
-7.99
-3.52
-2.65
-2.70
No of Public Share Holdings
76473250.00
76473250.00
76473250.00
65549280.00
% of Public Share Holdings
92.23
92.23
92.23
79.06
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
-68.31
-4.63
-1.32
-9.62
PBIDTM%
-68.31
-3.60
0.45
6.84
PBDTM%
-74.59
-11.63
-2.24
0.05
PBTM%
-103.53
-35.42
-25.68
-21.42
PATM%
-103.53
-35.42
-25.68
-21.86
 
Notes
Notes
Notes
Notes